ENGAGEMENT AMONG URBAN NATIVE COMMUNITIES AND HIV CLINICAL RESEARCH - - PowerPoint PPT Presentation

engagement among urban native
SMART_READER_LITE
LIVE PREVIEW

ENGAGEMENT AMONG URBAN NATIVE COMMUNITIES AND HIV CLINICAL RESEARCH - - PowerPoint PPT Presentation

USING A PARTICIPATORY MODEL OF ENGAGEMENT AMONG URBAN NATIVE COMMUNITIES AND HIV CLINICAL RESEARCH SITES: A CASE STUDY Michaela Grey (Din), MPH Katie Osterhage, MMS Jessica Velcoff, PhD Matt Ignacio (Tohono Oodham), MSSW 2013 USCA New


slide-1
SLIDE 1

USING A PARTICIPATORY MODEL OF ENGAGEMENT AMONG URBAN NATIVE COMMUNITIES AND HIV CLINICAL RESEARCH SITES: A CASE STUDY

Michaela Grey (Diné), MPH Katie Osterhage, MMS Jessica Velcoff, PhD Matt Ignacio (Tohono O’odham), MSSW

2013 USCA – New Orleans, LA September 10, 2013

slide-2
SLIDE 2

Welcome!

Introductions

NNAAPC & Legacy Overview

Cause & Effect Activity

HIV in Indian Country

NAEHCR Project Overview

Project Findings

Participatory Action Research (PAR)

NAEHCR Engagement Plan

NAEHCR Successes!

slide-3
SLIDE 3

Welcome!

Introductions

 Name  Where you are from  Role in community or agency

slide-4
SLIDE 4

NNAAPC and Legacy

slide-5
SLIDE 5

NNAAPC:

The National Native American AIDS Prevention Center (NNAAPC) helps organizations that serve Native communities to plan, develop and manage HIV/AIDS prevention, intervention, care and treatment programs.

slide-6
SLIDE 6

NNAAPC:

Our Vision:

 Indigenous communities free of HIV where health,

wellness and balance are celebrated Our Mission:

 To eliminate HIV/AIDS and confront related health

and social determinants that negatively impact American Indian, Alaska Native, Native Hawaiian and Indigenous peoples.

slide-7
SLIDE 7

Legacy Project

 Works nationally with communities that have been

underrepresented in HIV prevention, treatment, and clinical research through engagement, education, and scientific investigation.

 www.hanc.info/legacy/.

slide-8
SLIDE 8
slide-9
SLIDE 9

What is HIV Clinical Research?

Clinical trials take place all over the world and have led to many breakthroughs, such as:

1.

Preventing the spread of HIV

2.

Helping people living with HIV/AIDS to stay well longer

3.

Determine the safety and effectiveness of drugs and vaccines

slide-10
SLIDE 10

HIV Clinical Research

Clinical Trial Networks funded by NIH:

slide-11
SLIDE 11

HIV Clinical Research

Benefit the Individual

 Prevent Infection  Delay Disease

Benefit the Community

 Reduce Transmission  Healthier Communities

What does HIV Clinical Research do?

slide-12
SLIDE 12
slide-13
SLIDE 13

Cause and Effect

Activity:

slide-14
SLIDE 14

HIV in Indian Country

Estimated Diagnoses of HIV Infection among Adult and Adolescent American Indians/Alaska Natives by Transmission Category and Gender, United States (CDC, 2011)

slide-15
SLIDE 15

HIV in Indian Country: Context

 In 2011, 37% of Native women who acquired

the virus did so through injection drug use.

 This is the highest percentage of IDU acquisition among

women of all races and ethnicities.

 The number of new HIV infections among American

Indian or Alaska Native people has increased by 8.7% from 2007 to 2010.

 This is the greatest percent increase in new infections when

compared to all other races/ethnicities.

slide-16
SLIDE 16

HIV in Indian Country:

HOW DOES HIV/AIDS AFFECT THE NATIVE COMMUNITY?

 Native Hawaiians/Other Pacific Islanders and American

Indians/Alaska Natives had the 3rd and 4th highest rate of new HIV infections, respectively. By the end of 2008, the rate was 22.8 per 100,000 persons for NHOPIs and 11.9 per 100,000 for AI/ANs.

 Of persons who were diagnosed with HIV, AI/ANs had that shortest

  • verall survival time, with only 88% living longer than 3 years.

 Of persons who were diagnosed with HIV, almost 30% progressed

to an AIDS diagnoses in less than 12 months.

slide-17
SLIDE 17

HIV in Indian Country:

HIV TESTING Despite high rates of new HIV infections, 59% of American Indian/Alaska Natives have never been tested for HIV. Over 70% of Native Hawaiians and Other Pacific Islanders have never been tested for HIV.

slide-18
SLIDE 18
slide-19
SLIDE 19

National HIV/AIDS Strategy:

High Impact Prevention! Supported by 2010 National HIV/AIDS Strategy:

 Components of strategy are…

 Scientifically Proven (ART, P4P

, Drug Tx., CTRS)

 Cost-Effective  Scalable (wide-spread)

 Biomedical interventions  Targeted towards those at highest risk  In geographic areas “hardest hit”

slide-20
SLIDE 20

Legacy of Research

“The use of disease as a strategy of colonization, a history

  • f unethical research practice, and ongoing substandard

medical treatment has left many AI/AN individuals and communities distrustful.” (Duran &Walters, 2004) “People want collaborative research that is meaningful to the local communities…They don’t want ‘helicopter’ research anymore where people from the outside the tribe come into the community, collect their data, and then fly out with only the dust left. There is no data, no results and no discussion

  • f what the research was about.”

(Tom-Orne, 2012)

slide-21
SLIDE 21

Legacy of Research

History and analysis of poorly conducted research:

Barrow Alcohol Study (1979) Havasupai Diabetes Study (2004) National Geographic Genetics Study (2006)

slide-22
SLIDE 22

NAEHCR Project:

NAEHCR seeks to increase awareness and involvement

  • f urban Native communities in HIV clinical trials

Seattle (2011) Denver (2011) Chicago (2012) San Francisco (2012)

slide-23
SLIDE 23

NAEHCR Project:

 Building meaningful relationships between:

 Legacy Project and NNAAPC  Local CRS, Native community and NNAAPC  Local urban Native community, CRS and NNAAPC

 Not recruiting for clinical research!

slide-24
SLIDE 24

NAEHCR Project:

 Goal: Help increase awareness of HIV clinical research among

Native communities

 Goal: Help increase awareness of Native communities among

researchers

 Ensure that Native community members have the opportunity to

participate in HIV clinical research and benefit from biomedical breakthroughs

 Rooted Community-Based Participatory Research (CBPR) and

Participatory Action Research (PAR)

 Key: Establishing reciprocity and sustainability

slide-25
SLIDE 25

Participatory Action Research

Research and action must be done ‘with’ people and not ‘on’ or ‘for’ people.

slide-26
SLIDE 26

Kemmis and Mc Taggert (1988)

slide-27
SLIDE 27

Eliciting Stakeholder Buy-in & Feedback

  • One-to-One Meetings

with Leadership,

  • Public Kick-Off Event

Mixed Methods Evaluation

  • Formative and

Process Evaluations,

  • Qualitative and

Quantitative data Stakeholder involvement throughout process

  • Community

Consultants,

  • Program & Research
  • Design, Collection,

Interpretation, & Dissemination

slide-28
SLIDE 28

Reciprocal Education

  • Clinical Research

Training,

  • Cultural Humility

Training Meetings and Events

  • National Native

American HIV/AIDS Awareness Day,

  • F2F Meetings

Long Term Planning & Resources

  • Engagement

Template,

  • Research Brochures,
  • Publications
slide-29
SLIDE 29

PAR Activity

slide-30
SLIDE 30

NAEHCR Engagement Template

slide-31
SLIDE 31
slide-32
SLIDE 32

NAEHCR Findings:

Phase One (Denver and Seattle)

 2 Focus Groups: 16 ppl. Denver, 6 Seattle  4 Individual Interviews with CRS: 2 Denver, 2 Seattle  115 Surveys: 54 Denver, 61 Seattle

Phase Two (Chicago and San Francisco)

 2 Focus Groups: 14 ppl Chicago, 17 ppl San Francisco  5 Individual Interviews CRS staff, 2 Chicago, 3 San

Francisco

 121 Surveys: 61 Chicago, 60 Chicago

slide-33
SLIDE 33

NAEHCR Findings:

HIV is NOT Widely Discussed

slide-34
SLIDE 34

NAEHCR Findings:

Barriers to Effective Engagement

 Stigma toward PLWHA  Stigma toward LGBT/Two-Spirit Community  Mistrust of medical providers  Silence about sex

Facilitators of Effective Engagement

 Strong Sense of Community  Desire to Address HIV/AIDS Disparity  Emphasis on Community Health and Wellness

Components of Effective Engagement

 Straight Forward Approach  Intergenerational  Gender representation and diversity  Consistency/Visibility, “come to us.”  Native Representation/Leadership  Incorporate culture  Incentives

slide-35
SLIDE 35
slide-36
SLIDE 36

NAEHCR Successes!

 Continued funding beyond the

pilot phase

 Formal relationship between

researchers & local Native community

 Increased participant retention

in clinical trials (San Francisco & Denver)

 Standard Cultural Humility

Training now exists

 Option for linkage to medical

care

 Empowered community

members to speak about clinical research

 Finished Guidance document

for conducting another project similar to NAEHCR

 Discussing NAEHCR Project &

treatment advances removed the stigma associated with HIV

 CAB membership

slide-37
SLIDE 37

Denver Community Advisory Board Member

slide-38
SLIDE 38

Questions and Comments?

slide-39
SLIDE 39

THANK YOU!!!

Michaela Grey (Dine), MPH CBA Specialist mgrey@nnaapc.org (720) 382-2244 x304 Matt Ignacio (Tohono O’odham), MSSW Project Manager mignacio@nnaapc.org (720) 382-2244 x316 Katie Osterhage, MMS Project Manager kosterha@fhcrc.org (206) 667-2821 Jessica Velcoff, PhD jvelcoff@gmail.com

slide-40
SLIDE 40

Evaluation

http://goo.gl/zJxVqG